Managing Severe and Resistant Hypercholesterolemia (Apr, 2017)

Managing Severe and Resistant Hypercholesterolemia is organized by Rockpointe Corporation and Potomac Center for Medical Education (PCME) and would be held on Apr 28, 2017 at Sheraton Portland Airport Hotel, Portland, Oregon, United States of America.

This activity is intended for community-based cardiologists, internal medicine specialists, and other healthcare providers who manage severely dyslipidemic patients at high risk for adverse cardiovascular events. This CME Conference has been approved with a maximum of 1.0 AMA PRA Category 1 Credits.

Educational Objectives :

At the conclusion of this activity, participants should be able to demonstrate the ability to:

• Describe the consequences of directing moderate to intense statin treatment to identified at-risk populations, rather than treating to LDL-C target goals
• Evaluate extent of residual CVD risk to which high-risk dyslipidemic patients are exposed, and alter prescribing behavior to address additional CVD risk elements as appropriate
• Analyze the potential strengths and weaknesses of new approaches to reduce CVD risk with new LDL-C lowering agents as stand-alone treatments or in combination with statins.